Literature DB >> 7628277

Antiphospholipid antibodies in inflammatory bowel disease.

J C Souto, M Borrell, J Fontcuberta, M Roca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7628277     DOI： 10.1007/bf02285202

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction.

Authors:  A J Wakefield; A M Sawyerr; A P Dhillon; R M Pittilo; P M Rowles; A A Lewis; R E Pounder
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

Review 2.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

3.  Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects.

Authors:  P Vila; M C Hernández; M F López-Fernández; J Batlle
Journal:  Thromb Haemost       Date:  1994-08       Impact factor: 5.249

4.  Prevalence and significance of anticardiolipin antibodies in Crohn's disease.

Authors:  P Chamouard; L Grunebaum; M L Wiesel; J M Freyssinet; B Duclos; J P Cazenave; R Baumann
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

5.  Thromboembolism in inflammatory bowel disease: role of platelets.

Authors:  M J Webberley; M T Hart; V Melikian
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

6.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Authors:  A E Gharavi; E N Harris; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

7.  Evidence for activation of coagulation in Crohn's disease.

Authors:  M Hudson; R A Hutton; A J Wakefield; A M Sawyerr; R E Pounder
Journal:  Blood Coagul Fibrinolysis       Date:  1992-12       Impact factor: 1.276
  7 in total
  6 in total

1.  Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.

Authors:  Nora Sipeki; Laszlo Davida; Eszter Palyu; Istvan Altorjay; Jolan Harsfalvi; Peter Antal Szalmas; Zoltan Szabo; Gabor Veres; Zakera Shums; Gary L Norman; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

2.  Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Petinaki; E Anagnostopoulou; H Kritikos; I A Mouzas; E A Kouroumalis; O N Manousos
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 3.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

Review 4.  Structural brain lesions in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Hatice Dolapcioglu
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

5.  Activated protein C resistance, thrombophilia, and inflammatory bowel disease.

Authors:  M A Heneghan; B Cleary; M Murray; T A O'Gorman; C F McCarthy
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

Review 6.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.